How to Monitor Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Practice Tool Endorsed by Thrombosis Canada, the Canadian Stroke Consortium, the Canadian Cardiovascular Pharmacists Network, and the Canadian Cardiovascular Society

Ann Intern Med. 2015 Sep 1;163(5):382-5. doi: 10.7326/M15-0143.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • Atrial Fibrillation / complications*
  • Checklist*
  • Counseling
  • Drug Interactions
  • Drug Monitoring / methods*
  • Hemorrhage / chemically induced
  • Hemorrhage / prevention & control
  • Humans
  • Medication Adherence
  • Risk Assessment
  • Stroke / prevention & control*

Substances

  • Anticoagulants